copy and paste this google map to your website or blog!
Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples: WordPress Example, Blogger Example)
Edwards Lifesciences – the leading global structural heart innovation . . . Explore the life and culture of working at Edwards Lifesciences Join our passionate and innovative teams around the world Discover a career where your work transforms patient lives Kickstart your careers with impactful and meaningful work
Who we are - Edwards Lifesciences Who we are Edwards Lifesciences is the leading global structural heart innovation company, driven by a passion to improve patient lives
Careers | Edwards Lifesciences Edwards Lifesciences is the leading global structural heart innovation company, driven by a passion to improve patient lives Through breakthrough technologies, world-class evidence and partnerships with clinicians and healthcare stakeholders, our employees are inspired by our patient-focused culture to deliver life-changing innovations to
Locations - Edwards Lifesciences Headquartered in Irvine, California, our teams work together to create a sense of community and are focused on supporting what is best for Edwards and the patient
Edwards Lifesciences Reports Fourth Quarter Results Edwards’ unique portfolio of repair and replacement technologies for both Mitral and Tricuspid valves continues to deliver strong growth, with an increasing contribution to overall company performance
Edwards Lifesciences Corp - Overview Edwards Lifesciences is the leading global structural heart innovation company, driven by a passion to improve patient lives Through breakthrough technologies, world-class evidence and partnerships with clinicians and healthcare stakeholders, our employees are inspired by our patient-focused culture to deliver life-changing innovations to
Newsroom - Edwards Lifesciences About us Edwards Lifesciences is the leading global structural heart innovation company, driven by a passion to improve patient lives
Press Releases | Edwards Lifesciences FDA Approves Edwards Lifesciences' SAPIEN M3 Mitral Valve Replacement System as First Transseptal Transcatheter Therapy Read more December 18, 2025